Article
Real-World Study Finds Similar Rates of GA Lesion Growth During Treatment With Izervay or Syfovre
Josh O. Wallsh, MD, presented a same-eye comparison of avacincaptad pegol and pegcetacoplan at ASRS 2026, finding no statistically significant difference in geographic atrophy lesion growth rates.







